|
LOC727896 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.64949999995157E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.34249999999858E-05 |
| Normal-vs-Stage2 |
9.07989999965331E-07 |
| Normal-vs-Stage3 |
2.17930000045996E-07 |
| Normal-vs-Stage4 |
1.74730000002121E-06 |
| Stage1-vs-Stage2 |
3.383700E-02 |
| Stage1-vs-Stage3 |
3.983200E-03 |
| Stage1-vs-Stage4 |
1.014430E-01 |
| Stage2-vs-Stage3 |
7.638000E-01 |
| Stage2-vs-Stage4 |
8.325600E-01 |
| Stage3-vs-Stage4 |
5.932400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.71529999998454E-06 |
| Normal-vs-AfricanAmerican |
1.25719999966023E-07 |
| Normal-vs-Asian |
1.443380E-04 |
| Caucasian-vs-AfricanAmerican |
4.092400E-02 |
| Caucasian-vs-Asian |
5.489000E-01 |
| AfricanAmerican-vs-Asian |
2.854400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.70690000003793E-06 |
| Normal-vs-Female |
3.54810000002814E-06 |
| Male-vs-Female |
6.266200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.97820000000082E-05 |
| Normal-vs-Age(41-60Yrs) |
2.22579999997752E-06 |
| Normal-vs-Age(61-80Yrs) |
1.46730000039064E-07 |
| Normal-vs-Age(81-100Yrs) |
1.225190E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.119970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.500200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.492600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.015640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.044600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.422400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.660100E-03 |
| Classical-VS-Follicular |
8.856000E-03 |
| Classical-VS-Other |
7.665000E-01 |
| Classical-VS-Normal |
5.71129999999975E-05 |
| Tall-VS-Follicular |
5.281000E-01 |
| Tall-VS-Other |
3.000600E-01 |
| Tall-VS-Normal |
2.06149999959493E-07 |
| Follicular-VS-Other |
5.608800E-01 |
| Follicular-VS-Normal |
5.5106999996557E-07 |
| Other-VS-Normal |
6.797600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.1021999996893E-07 |
| Normal-vs-N1 |
1.843960E-04 |
| N0-vs-N1 |
7.211900E-02 |
|
|
